首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   60344篇
  免费   7688篇
  国内免费   1611篇
耳鼻咽喉   253篇
儿科学   1146篇
妇产科学   666篇
基础医学   3184篇
口腔科学   2478篇
临床医学   9133篇
内科学   6552篇
皮肤病学   852篇
神经病学   2711篇
特种医学   1327篇
外国民族医学   11篇
外科学   5377篇
综合类   11444篇
现状与发展   6篇
一般理论   28篇
预防医学   6400篇
眼科学   875篇
药学   7754篇
  559篇
中国医学   5508篇
肿瘤学   3379篇
  2024年   307篇
  2023年   1436篇
  2022年   2436篇
  2021年   3850篇
  2020年   4193篇
  2019年   2969篇
  2018年   2703篇
  2017年   3093篇
  2016年   3127篇
  2015年   2650篇
  2014年   4700篇
  2013年   5009篇
  2012年   3944篇
  2011年   3980篇
  2010年   3053篇
  2009年   2661篇
  2008年   2555篇
  2007年   2655篇
  2006年   2242篇
  2005年   1877篇
  2004年   1577篇
  2003年   1411篇
  2002年   1124篇
  2001年   902篇
  2000年   726篇
  1999年   554篇
  1998年   501篇
  1997年   437篇
  1996年   391篇
  1995年   308篇
  1994年   316篇
  1993年   228篇
  1992年   241篇
  1991年   199篇
  1990年   179篇
  1989年   171篇
  1988年   155篇
  1987年   134篇
  1986年   103篇
  1985年   116篇
  1984年   88篇
  1983年   49篇
  1982年   66篇
  1981年   48篇
  1980年   40篇
  1979年   29篇
  1978年   20篇
  1977年   16篇
  1976年   20篇
  1975年   21篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
探讨了金氏医案中所体现的学术思想,论述了金氏临旆重视阴阳五行、挈中气机要领、把握升降关键、擅调先天后天的治疗特点,阐述了其临床重视四诊合参、炮制遗药注重实效的治学精神和求实作用。  相似文献   
92.
目的 研究年轻成人Perthes病的临床表现与MRI表现的相关性。方法 对 12例有或无症状年轻成人Perthes病患者作X线和MRI检查 ,测量CE角、ATD、髋臼商、头颈商、关节内侧间隙和髋臼覆盖率等X线指标 ,以及关节积液、外侧关节囊厚度等MRI表现。统计分析其与临床表现的相关性。结果 MRI检查显示外侧关节囊厚度与愈合后遗的症状有相关性 ,关节积液量有明显的差异趋势 ,但因样本量过少 ,统计学分析无差异 ,各项X线测量指标亦未显示明显的相关性。结论 外侧关节囊厚度与年轻成人Perthes病的临床表现有一定相关性。  相似文献   
93.
为了提高进修医师的教学质量和医疗水平,我们在2006届进修医师教学工作中加强和细化了进修医师接诊前的培训,取得了良好的效果.实践证明,实施接诊前培训对于提高进修医师的医疗水平和自信心,实施规范化操作,克服诊疗中的盲目性,减少或避免医疗纠纷,进而提高进修医师的教学质量具有重要意义,值得推广和借签.  相似文献   
94.
95.
BackgroundRacial and ethnic disparities in access to hip and knee total joint arthroplasty (TJA) and postoperative outcomes have wide-reaching implications for patients and the health care system. The aim of this study is to evaluate the effect of ethnicity on clinical outcomes and complications following revision hip and knee TJA.MethodsA single-institution, retrospective analysis of a consecutive series of 4424 revision hip and knee TJA patients was evaluated. Student’s t-test and chi-squared analysis were used to identify significant differences in patient demographics and clinical outcomes between Caucasians and various ethnic minorities, including African Americans, Hispanics, and Asians.ResultsWhen compared with white patients, African American patients demonstrated a significantly higher BMI (P = .04), ASA score (P = .04), length of hospital stay (P = .06), and postoperative infection rates (P = .04). Hispanics demonstrated a significantly higher BMI (P = .04), when compared with white patients, alongside a significantly higher risk for postoperative infection (P < .01). African American demonstrated a significantly higher ASA score (P = .02; P = .03), when compared with Hispanics and Asians, alongside a significantly increased length of stay (P = .01) and higher risk for postoperative infection (P = .02).ConclusionThe study findings demonstrate an underutilization of revision TJA by ethnic minority groups, suggesting that disparities in access to orthopedic surgery increase from primary to revision surgery despite higher failure rates of minority ethnic groups reported after primary TJA surgery. In addition, inferior postoperative outcomes were associated with African Americans and Hispanics, when compared to white patients, with African Americans demonstrating the highest risk of postoperative complications.  相似文献   
96.
97.
98.
Molecular mismatch analysis for assessment of histocompatibility in transplantation requires high-resolution HLA typing. Algorithms to “guesstimate” high-resolution from low-resolution typing exist, but their accuracy remains unknown. We converted high-resolution, sequence-based, HLA typing of 310 subjects from an ethnically heterogeneous population to low-resolution equivalents and tested the ability of the NMDP HaploStats and HLA Matchmaker programs to impute/reproduce the measured high-resolution HLA type, using the more common “winner-takes-all” approach. Only 35.6% of the HaploStats imputed HLA-A, -B, -C, -DRB1, and -DQB1 haplotypes had no mistakes, and the accuracy was significantly lower for non-Caucasians (29.1%) compared to Caucasians (45.2%) (odds ratio [OR], 0.5; 95% confidence interval [CI], 0.3-0.8; P = .004). HLA Matchmaker was not able to provide high-resolution haplotypes for 45.2% of Caucasian subjects and 63.5% of non-Caucasian subjects (P = .002). Of those with an imputed result, only 10.3% of Caucasians and 4.8% of non-Caucasians had accurate 10-allele high-resolution output. Eplet analysis revealed additional, inaccurate eplets in 37% of individuals, with 22.5% showing at least 2 additional, inaccurate eplets; incorrect eplets were more common among non-Caucasians (OR, 1.8; 95% CI, 1.1-2.9; P = .018). Given this high error rate, caution should be taken before using imputation tools for clinical or research purposes, especially for non-Caucasian individuals.  相似文献   
99.
100.
Outcomes following hepatitis C virus (HCV)-viremic heart transplantation into HCV-negative recipients with HCV treatment are good. We assessed cost-effectiveness between cohorts of transplant recipients willing and unwilling to receive HCV-viremic hearts. Markov model simulated long-term outcomes among HCV-negative patients on the transplant waitlist. We compared costs (2018 USD) and health outcomes (quality-adjusted life-years, QALYs) between cohorts willing to accept any heart and those willing to accept only HCV-negative hearts. We assumed 4.9% HCV-viremic donor prevalence. Patients receiving HCV-viremic hearts were treated, assuming $39 600/treatment with 95% cure. Incremental cost-effectiveness ratios (ICERs) were compared to a $100 000/QALY gained willingness-to-pay threshold. Sensitivity analyses included stratification by blood type or region and potential negative consequences of receipt of HCV-viremic hearts. Compared to accepting only HCV-negative hearts, accepting any heart gained 0.14 life-years and 0.11 QALYs, while increasing costs by $9418/patient. Accepting any heart was cost effective (ICER $85 602/QALY gained). Results were robust to all transplant regions and blood types, except type AB. Accepting any heart remained cost effective provided posttransplant mortality and costs among those receiving HCV-viremic hearts were not >7% higher compared to HCV-negative hearts. Willingness to accept HCV-viremic hearts for transplantation into HCV-negative recipients is cost effective and improves clinical outcomes.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号